How effective is it to switch among atypical antipsychotics? A randomized, open-label study of algorithm-based antipsychotic treatment to symptomatic patients with schizophrenia in a real-world clinical setting

被引：0
|
作者：
Suzuki, T.
Uchida, H.
Watanabe, K.
Tanabe, A.
Tsunoda, K.
Nomura, K.
Niou, S.
Takeuchi, H.
Yagi, G.
Kashima, H.
机构：
[1] Keio Univ, Sch Med, Dept Neuropsychiat, Tokyo, Japan
[2] Inokashira Hosp, Tokyo, Japan
来源：
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY | 2006年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S269 / S269
页数：1
相关论文
共 44 条
  • [41] Randomized, observational study of long-term entecavir treatment versus other standard of care nucleos(t)ide analog therapy in nucleos(t)ide-naive patients with chronic hepatitis B from a 'real-world' clinical practice setting in China
    Hou, Jinlin
    Jia, Jidong
    Wei, Lai
    Ren, Hong
    Xie, Qing
    Gao, Zhi-liang
    Zhao, Wei
    Wang, Yuming
    Gong, Guozhong
    Cao, Wukui
    Yu, Miao
    Llamoso, Cyril
    HEPATOLOGY, 2012, 56 : 384A - 384A
  • [42] Osimertinib in advanced or metastatic non-small cell lung cancer patients with EGFR T790M mutation after treatment with EGFR-TKI: Interim analysis of China cohort from the single-arm, open-label, international, multi-center real-world ASTRIS study
    Zhou, Q.
    Zhang, H.
    Jiang, L.
    Shi, Y.
    Chen, Y.
    Yu, J.
    Zhou, C.
    He, Y.
    Hu, Y.
    Liang, Z-A.
    Pan, Y.
    Zhuo, W.
    Song, Y.
    Wu, G.
    Chen, G.
    Lu, Y.
    Cheng, Y.
    Lu, S.
    Wang, J.
    Wu, Y. L.
    ANNALS OF ONCOLOGY, 2018, 29 : 158 - 158
  • [43] Methodology of EARLIMS Study: A Multi-Center, Open-Label, Non-Randomized, Parallel Group Clinical Trial To Assess the Efficacy of Fingolimod in Treatment-Naive Patients Versus Fingolimod in Patients Previously Treated with Interferons or Glatiramer Acetate, Based on the Presence of Relapses in Patients with Relapsing-Remitting Multiple Sclerosis
    Montalban, Xavier
    Fernandez, Oscar
    Luisa Gobartt, Ana
    NEUROLOGY, 2012, 78
  • [44] Triple-Arm, Prospective, Multicentre, Randomized, Open-Label, Active-Controlled Study to Assess Effect on FDC of Teneligliptin 20 mg + Dapagliflozin 10 mg Compared with FDC of Sitagliptin 100 mg + Dapagliflozin 10 mg and FDC of Linagliptin 5 mg+ Empagliflozin 25 mg on 24-Hour Glucose Profile Assessed by Continuous Glucose Monitoring (CGM) in Indian Patients of Type 2 Diabetes Mellitus In Real-World Setting (AMPLIFY-TIR STUDY)-Interim Report
    Barkate, Hanmant V.
    Petare, Anup U.
    Bhushan, Sumit
    Choudhari, Sanjay Y.
    Brid, Manasi
    Patil, Saiprasad
    DIABETES, 2024, 73
12345